Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON27808Active, not recruiting
Open-label, single-arm trial of ciprofloxacin, vancomycin and metronidazole, sponsored by Amsterdam University Medical Center. Primary endpoints: Side effects, Laboratory parameters for inflammatory responses and 2 more. Started Mar 2012; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON27808.